Nagstatin (1) 
Herein, we describe the syntheses and evaluation of the glycosidase inhibiting activities of analogs 2~6 as Scheme 1.
Scheme 3.
The nomenclature conveniently parallels that of carbohydrates. part of an ongoing program3) to clarify the modeof action of glycosidase inhibitors. Both compounds8 and 9 were effectively converted into 2 and 3 as follows. De-JV-tritylation and the SN2-type intramolecular cyclization of 8 were realized in one-pot by reaction with BnSO2Cl in pyridine at -15°C for 1.5hours to give preferentially the 9-O-sulfonylated compound followed by treatment with Ac2Oat 65°C for Galactosaminidaseh   >100  >100  > 100  77  >100  >100  >100  >100  >100  >100  > 25 >100 21 >100 32 0.14 3.5 > 100 2.5 0.12 > 100 60 >100 >100 >100 >100 0.0017 >100 >100 >100 >100 >100 >100 >100 >100 >100 0.023 > 100 > 100 > 1.00 > 100 >100 >100 71 ' >"100 >100 31 >100 >100 >100 >100
Bakers yeast; bAlmonds; cJack beans; d Snail; e Escherichia coli; f Escherichia coli; g Bovine kidney; h Chicken liver.
The azide 23 was also obtained from 24 with retention of the C-8 configuration as described in the preparation of 12 from 15. The intermediate 24 was prepared from 19 by benzylsulfonylation and acetylation with cyclization followed by de-O-acetylation as described in the preparation of 15 from 9, and also derived from 22 in 85% overall yield by Mitsunobu inversion with BzOH followed by de-O-benzoylation. Then, the D-glucose analog 5 (Table  1) 
